ZB-002
- Generic Name
- ZB-002
A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis
Phase 1
Recruiting
- Conditions
- Healthy VolunteersRheumatoid Arthritis
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Zenas BioPharma (USA), LLC
- Target Recruit Count
- 72
- Registration Number
- NCT05638854
- Locations
- 🇦🇺
Veritus Research, Melbourne, Australia
🇳🇿NZCR New Zealand Clinical Research, Christchurch, New Zealand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath